Mangoceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $67 | $94 | $84 | $168 |
Gross Profit | 29 | 47 | 50 | 89 |
EBITDA | -3,126 | -7,518 | -4,557 | |
EBIT | -3,403 | -7,542 | -5,394 | |
Net Income | -3,403 | -2,769 | -7,618 | -5,415 |
Net Change In Cash | 67 | 94 | 84 | 168 |
Free Cash Flow | -1,311 | -1,077 | -1,241 | -1,256 |
Cash | 174 | 1,486 | 481 | 101 |
Basic Shares | 10,071 | 15,888 | 11,524 | 9,983 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $456 | $615 | $731 | $8 |
Gross Profit | 250 | 379 | 431 | 4 |
EBITDA | -18,815 | -7,962 | -8,093 | -1,987 |
EBIT | -20,539 | -8,683 | -8,118 | -1,991 |
Net Income | -20,643 | -8,706 | -9,212 | -1,998 |
Net Change In Cash | 456 | 615 | 731 | 8 |
Free Cash Flow | -5,850 | -4,863 | -7,000 | -1,389 |
Cash | 1,486 | 58 | 739 | 682 |
Basic Shares | 10,071 | 1,978 | 1,074 | 1,154 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.22 |
2025-12-31 | -$0.19 |
2025-09-30 | -$0.69 |
2025-06-30 | -$0.54 |